06/23/2014
https://congress.gov...
"Biosimilars hold the potential to help cut down these costs with marketed biosimilars being priced an average of 40 percent less than the biologic."
"I hope that the Americans are watching because 1 out of every $5 in Americans' wallets somehow some way goes back into their healthcare needs."
"I was impressed to learn that Kaiser Permanente has taken such a leading stance on biosimilar utilization."
"has HHS already instituted policies, protocols, and procedures to limit harm to children and their families during these separations?"